# Assessment of a Large US EHR Database as Meeting FDA Fit-for-Purpose Requirements to Provide External Controls for Study BPM31510 in Participants With Glioblastoma

> **NCT07674095** · — · ACTIVE_NOT_RECRUITING · sponsor: **BPGbio** · enrollment: 150 (estimated)

## Conditions studied

- Glioblastoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07674095
- **Lead sponsor:** BPGbio
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-03-01
- **Primary completion:** 2026-07-01
- **Final completion:** 2026-09-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-07-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07674095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07674095, "Assessment of a Large US EHR Database as Meeting FDA Fit-for-Purpose Requirements to Provide External Controls for Study BPM31510 in Participants With Glioblastoma". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07674095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*